Harvard-Vision Clinical Scientist Development Program

哈佛视觉临床科学家发展计划

• 批准号: 9910394
• 负责人: Reza Dana
• 金额: $ 51.33万
• 依托单位: MASSACHUSETTS EYE AND EAR INFIRMARY
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-09-30 至 2021-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9910394
• 关键词: Advisory Committees; Area; Award; Basic Science; Benchmarking; Bioethics; Biometry; Clinical; Clinical Sciences; Clinical effectiveness; Custom; Degree program; Doctor of Philosophy; Educational Curriculum; Enrollment; Environment; Eye diseases; Faculty; Funding; Grant; Growth; Immersion; Lead; Learning; Link; Mentored Clinical Scientist Development Program; Mentors; Molecular; Ophthalmology; Process; Program Development; Reporting; Research; Research Design; Science; Scientist; Structure; Surveys; Time; Training; Training Programs; Translational Research; Vision; Vision research; Writing; base; experience; meetings; member; multidisciplinary; notch protein; programs; recruit; research and development; responsible research conduct; virtual; vision science

 DESCRIPTION (provided by applicant): The extraordinary growth and specialization that has occurred in the sciences has made it difficult to link the increasing divide between clinical and basic science components of ophthalmic and vision sciences. Translational research has suffered as a consequence. The Harvard Department of Ophthalmology is one of the largest academic departments of Ophthalmology in the nation. With over 172 full-time clinical and basic science faculty members, it makes significant contributions to ophthalmic and vision research in virtually all basic, applied, and clinical subspecialty areas. The Harvard Department of Ophthalmology K12 program offers a customized and structured learning, research, and development environment to a select and diverse group of highly-qualified, clinically-trained candidates who have recently completed (or are about to complete) their training, but who desire further mentored learning experience so as to become independent clinical scientists in their respective fields. Scholar candidates in this program will (i) complete a core curriculum tha will include (a) the Harvard Program in Clinical Effectiveness - a summer-long immersion program in biostatistics and study design, (b) HBTM 305qc. "The Molecular Bases of Eye Disease", a multidisciplinary survey course focusing on the cellular and molecular mechanisms of eye disease, (c) training in Responsible Conduct of Research and Bioethics, and (d) participation in Grant Writing courses. Scholars will also (ii) perform research in a closely mentored program under the guidance of lead mentors who are leaders in their respective fields. Trainees in this program will additionally have the option of seeking an advanced degree (MS, MPH, PhD, ScD) at Harvard. This is a competitive renewal application for the Harvard Ophthalmology K12 program, which has been very successful to date in meeting its benchmarks of recruiting and training top-notch clinician-scientists in a mentored environment. Since 2010, the program has received 44 inquiries, from which 16 were invited to complete the formal application process. Of these 16 applicants, five (31%) were accepted into the program. Scholars in the program have been highly productive in research, have completed or enrolled in degree programs, and received national academic and research awards and grants. Importantly, since the start of our program in 2004 all the Scholars who have completed the program have been awarded RO1 funding from NEI. We intend to enroll 4 scholars in the next renewal cycle (5 years) and each scholar will continue in the program for an estimated 3 years per the newly NEI-mandated 3-year cap per Scholar. The progress of Scholars is reported by the Program Director twice annually to the Program Advisory Committee and annually to the External Advisory Committee, comprised of leading vision and ophthalmic scientists and educators in our nation. Our aim is to build on our progress to date, and continue our training program for an additional 5 years.

 描述（由申请人提供）：科学领域的飞速发展和专业化使得眼科和视觉科学的临床和基础科学部分之间日益扩大的分歧变得难以联系起来，哈佛大学系因此受到影响。眼科是美国最大的眼科学术院系之一，拥有超过 172 名全职临床和基础科学教员，为几乎所有领域的眼科和视力研究做出了重大贡献。哈佛眼科 K12 项目为刚刚完成（或即将完成）的高素质、经过临床培训的候选人群体提供定制和结构化的学习、研究和发展环境。即将完成）他们的培训，但希望获得进一步指导的学习经验，以便成为各自领域的独立临床科学家，该计划的学者候选人将（i）完成核心课程，其中包括（a）哈佛临床计划。有效性-a为期夏季的生物统计学和研究设计沉浸式课程，(b) HBTM 305qc“眼部疾病的分子基础”，这是一个专注于眼部疾病的细胞和分子机制的多学科调查课程，(c) 负责任的研究行为培训。和生物伦理学，以及（d）参与资助写作课程（ii）在各自领域的领导者的指导下，在密切指导的项目中进行研究。此外，您还可以选择在哈佛大学攻读高级学位（MS、MPH、PhD、ScD）。这是哈佛眼科 K12 项目的竞争性更新申请，迄今为止，该项目在满足其招聘和培训基准方面非常成功。自 2010 年以来，该计划已收到 44 份询问，其中 16 名申请者受邀完成正式申请流程。 (31%) 被该项目录取的学者在研究方面取得了很高的成果，已经完成或注册了学位课程，并获得了国家学术和研究奖项和助学金。完成该项目的学者已获得 NEI 的 RO1 资助，我们打算在下一个更新周期（5 年）招收 4 名学者，根据新的 NEI 授权，每位学者将继续参与该项目预计 3 年。每位学者的任期为 3 年。项目主任每年两次向项目咨询委员会报告学者的进展情况，并每年向由我国领先的视力和眼科科学家和教育工作者组成的外部咨询委员会报告。我们迄今为止取得的进展，并继续我们的培训计划 5 年。